top of page
Michael C. Fulton M.D_.jpg
Michael Fulton, MD

Senior Managing Director Fund IV

Dr. Fulton has spent his entire career in healthcare, including over 20 years as a successful early-stage investor and entrepreneur. Prior to joining BioStar, Dr. Fulton was a Managing Director of Hopen Life Science Ventures, a healthcare-focused venture capital firm, where he sourced and led a number of deals and has represented the firm on multiple Boards. Before transitioning to venture capital, he was a medical device and healthcare services entrepreneur, most notably at Lanx, Inc., a device company he co-founded in the spinal implant space. Over a span of eight years as CEO of Lanx, he scaled the company from a business plan into an $85 million revenue, 225-employee corporation that was ultimately acquired by Biomet. Dr. Fulton was also a co-founder, director, and interim CEO of ProNerve, an interoperative neuromonitoring company that was acquired by a private-equity group. He is an inventor of multiple neurosurgical and spinal devices, with over 50 granted U.S. and international patents. Dr. Fulton received his B.A. from Northwestern University and his M.D. from Cornell University Medical College. He also completed two years of neurosurgery training at the Cleveland Clinic. Dr. Fulton is a Senior Managing Director of Fund IV and an Entrepreneur in Residence of Fund V.

bottom of page